ARCHIVES

House Aims to End Budget Markup Early; Natcher Sees Most Difficult Year

This article is from The Cancer Letter archive.

Vol. 18 No. 26 | June 26, 1992

Download PDF Visit The Full Archive

Related Articles

Miami Core Grant Not Renewed, Status Threatened

September 21, 1990

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

April 13, 1990

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

October 23, 2009

Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting.

April 16, 2004

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992